Skip to main content

Table 1 Baseline demographic and tumor characteristics by primary payer statusa

From: The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: a comprehensive study covering diagnosis, treatment, and outcomes

Characteristics

Overall n (%)

High reimbursement rate, n (%)

Low reimbursement rate, n (%)

P

CCI

 0

490(18.54)

207(14.59)

283(23.12)

<.0001

 1~ 3

2085(78.89)

1174(82.73)

911(74.43)

 

 4~

68(2.57)

38(2.68)

30(2.45)

 

Gender

 male

1677(63.45)

939(66.17)

738(60.29)

0.0018

 female

966(36.55)

480(33.83)

486(39.71)

 

Age

  < 40

82(3.10)

33(2.33)

49(4.00)

<.0001

 40~

445(16.84)

192(13.53)

253(20.67)

 

 50~

1083(40.98)

600(42.28)

483(39.46)

 

 60~

1033(39.08)

594(41.86)

439(35.87)

 

Smoking

 no

1174(44.42)

631(44.47)

543(44.36)

0.9567

 yes

1469(55.58)

788(55.53)

681(55.64)

 

Family history of NSCLC

 none

2494(94.36)

1324(93.31)

1170(95.59)

0.0112

 have

149(5.64)

95(6.69)

54(4.41)

 

primary lesion site

 left

1051(39.77)

560(39.46)

491(40.11)

0.9437

 right

1416(53.58)

764(53.84)

652(53.27)

 

 other

176(6.66)

95(6.69)

81(6.62)

 

Historical stage

 High differential

302(11.27)

189(13.32)

112(9.15)

<.0001

 Moderately differential

710(26.50)

412(29.03)

294(24.02)

 

 Low differential

779(29.08)

371(26.15)

397(32.43)

 

 unknown

868(32.84)

447(31.50)

421(34.40)

 

Histological classification

 Squamous carcinoma

956(36.17)

483(34.04)

437(38.64)

0.0063

 adenocarcinoma

1334(50.47)

759(53.35)

577(47.14)

 

 other

353(13.36)

179(12.61)

174(14.22)

 

Procedure class

 lobectomy

1576(59.63)

876(61.73)

210(55.56)

0.0049

 wedge resection

67(2.53)

45(3.17)

6(1.59)

 

 pneumonectomy

229(8.66)

104(7.33)

34(8.99)

 

 exploratory thoracotomy

771(29.17)

394(27.77)

128(33.86)

 

Bronchial stump

 negative

1696(64.17)

923(65.05)

773(63.15)

0.5386

 positive

43(1.63)

24(1.69)

19(1.55)

 

 unknown

904(34.20)

472(33.26)

432(35.29)

 

Clinical stages

 IA

559(21.15)

333(23.47)

226(18.46)

0.0065

 IB

426(16.12)

213(15.01)

213(17.40)

 

 IIA

325(12.30)

183(12.90)

142(11.60)

 

 IIB

124(4.69)

64(4.51)

60(4.90)

 

 IIIA

607(22.97)

301(21.21)

309(25.00)

 

 IIIB

147(5.56)

71(5.00)

76(6.21)

 

 IV

455(17.22)

254(17.90)

201(16.42)

 

Hospital type

 Specialized

1480(56.00)

741(52.22)

739(60.38)

<.0001

 General

1163(44.00)

678(47.78)

485(39.62)

 

Average per capital income

 High income

465(17.59)

416(29.32)

49(4.00)

<.0001

 Low income

2178(82.41)

1003(70.68)

1175(96.00)

 
  1. aData are expressed as numbers and percentages of patients. Percentages may not sum up to 100% due to round-off.Abbreviations: CCI the Charlson comorbidity index, NSCLC non-small cell lung cancer